S135 The clinical impact of Streptococcus pneumoniae serotype shift to non-PCV13 vaccine serotypes
Sign Up to like & getrecommendations! Published in 2019 at "Thorax"
DOI: 10.1136/thorax-2019-btsabstracts2019.141
Abstract: Introduction Conjugate vaccines reduce Streptococcus pneumoniae vaccine serotype circulation with replacement with non-vaccine serotypes. The clinical impact of this remains uncertain, in particular how adult pneumococcal disease may have changed following the replacement of PCV7… read more here.
Keywords: serotype shift; disease; non pcv13; pcv13 ... See more keywords
Higher valency vaccines’ impact on antimicrobial resistance rates in Streptococcus pneumoniae causing invasive disease: a retrospective analysis based on national reference laboratory data, Belgium, 2018 to 2023
Sign Up to like & getrecommendations! Published in 2025 at "Eurosurveillance"
DOI: 10.2807/1560-7917.es.2025.30.45.2500179
Abstract: BACKGROUND Fifteen- and 20-valent pneumococcal conjugate vaccines (PCVs) offer broader protection against invasive pneumococcal disease (IPD) than PCV13. Adopting these vaccines may result in decreasing IPD incidence, antibiotic use and antimicrobial resistance (AMR) rates. If… read more here.
Keywords: resistance; retrospective analysis; pcv20; non pcv13 ... See more keywords